Mu dheidhinn aillse / làimhseachadh / drogaichean / ioma-myeloma

Drogaichean ceadaichte airson ioma-myeloma agus neoplasms cealla plasma eile

Tha an duilleag seo a ’liostadh dhrogaichean aillse a chaidh aontachadh leis an Rianachd Bidhe is Drugaichean (FDA) airson iomadach myeloma agus neoplasms cealla plasma eile. Tha an liosta a ’toirt a-steach ainmean gnèitheach, ainmean branda, agus cothlamadh dhrogaichean cumanta, a tha air an sealltainn ann an litrichean mòra. Tha na h-ainmean dhrogaichean a ’ceangal ri geàrr-chunntasan Fiosrachadh Drogaichean aillse NCI. Is dòcha gu bheil drogaichean air an cleachdadh ann an iomadach myeloma agus neoplasms cealla plasma eile nach eil air an liostadh an seo.

Drogaichean ceadaichte airson ioma-myeloma agus neoplasms cealla plasma eile

Alkeran airson stealladh (Hydrochloride Melphalan)

Clàran Alkeran (Melphalan)

Aredia (Pamidronate Disodium)

BiCNU (Carmustine)

Bortezomib

Carfilzomib

Carmustine

Cyclophosphamide

Daratumumab

Darzalex (Daratumumab)

Doxil (Doxorubicin Hydrochloride Liposome)

Liposome Hydrochloride Doxorubicin

Elotuzumab

Empliciti (Elotuzumab)

Evomela (Hydrochloride Melphalan)

Farydak (Panobinostat)

Ixazomib Citrate

Kyprolis (Carfilzomib)

Lenalidomide

Melphalan

Hydrochloride Melphalan

Mozobil (Plerixafor)

Ninlaro (Ixazomib Citrate)

Pamidronate Disodium

Panobinostat

Plerixafor

Pomalidomide

Pomalyst (Pomalidomide)

Revlimid (Lenalidomide)

Selinexor

Thalidomide

Thalomid (Thalidomide)

Velcade (Bortezomib)

Xpovio (Selinexor)

Acid Zoledronic

Zometa (Zoledronic Acid)

Measgachadh dhrogaichean air a chleachdadh ann an ioma-myeloma agus neoplasms cealla plasma eile

PAD